IP 254 (Ranitidine 300 mg)
Pill with imprint IP 254 is Yellow, Capsule-shape and has been identified as Ranitidine hydrochloride 300 mg. It is supplied by Amneal Pharmaceuticals.
Ranitidine is used in the treatment of gerd; erosive esophagitis; duodenal ulcer; gastric ulcer maintenance treatment; duodenal ulcer prophylaxis (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 300 mg is not a controlled substance under the Controlled Substance Act (CSA).
Images for IP 254
Ranitidine hydrochloride
- Imprint:
- IP 254
- Strength:
- 300 mg
- Color:
- Yellow
- Shape:
- Capsule-shape
- Availability:
- Rx and/or OTC
- Drug Class:
- H2 antagonists
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Amneal Pharmaceuticals
- National Drug Code (NDC):
- 53746-0254
More about ranitidine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 99 Reviews – Add your own review/rating
- Drug class: H2 antagonists
Consumer resources
- Ranitidine
- Ranitidine Injection
- Ranitidine Suspension
- Ranitidine Tablets and Capsules
- Ranitidine Syrup
Other brands: Zantac, Zantac 150, Zantac 300, Zantac 75, ... +2 more
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
